Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination Well-t ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Company to host conference call and webcast today at 8:00 A.M. ET ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

Doctors favor treatment with continuous positive airway pressure (CPAP) machines, researchers are slated to report this week ...

Obesity medicine physician Dr. Alexandra Sowa reacts to a study indicating GLP-1 weight loss medications potentially increase ...

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...

Nurse practitioner Shawnda Dorantes says weight-loss drugs are “helping people reclaim their health and confidence like never ...

While the medications may reduce diet, the best results will be achieved by building healthy habits alongside the drugs.

One woman has spoken out about a negative side effect of weight loss jabs that no one really talks about, despite losing a ...

CVS Caremark identified GLP-1 drugs and Humira as points of contention, but the State Health Plan says that mischaracterizes ...

A bipartisan bill soon to be introduced in the state Legislature seeks to decrease the cost of GLP-1 drugs in Pennsylvania.